Related Experiment Video
Updated: Mar 29, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma
1Department of Thoracic Surgery, The Third Xiangya Hospital, Central South University No 138 Tong-Zipo Road, Changsha 410013, Hunan Province, P. R. China.
Background:
microRNAs (miRNAs) play a significant role in cancer development and progression by regulating the expression of oncogenes or tumor suppressor genes. Previous study using microarrays demonstrated that miR-142-3p was downregulated in patients with Non-small-cell lung carcinoma (NSCLC). However, the functional role of miR-142-3p in NSCLC is still unclear.
Material And Method:
Real-time quantitative PCR was applied to evaluate the expression level of miRNA-142-3p in NSCLC and normal samples. The cell proliferation of NSCLC cells was analyzed by MTT and colony formation assay after miR-142-3p transfection. Luciferase activities assay, cotransfection and Western blot were used to reveal that the predicted target genes of miR-125b were direct and specific.
Results:
In this study, we demonstrate miR-142-3p was downregulated in NSCLC tissues and cell lines. We demonstrated that the overexpression of miR-142-3p inhibits NSCLC cell proliferation and induced cell apoptosis. Furthermore, we demonstrate HMGB1 was a directly target of miR-142-3p in NSCLC cells, and confirmed the target specificity between miR-142-3p and the HMGB1 3'-untranslated region by luciferase reporter assay.
Conclusions:
These results suggest that miR-142-3p may be a tumor suppressor through the downregulation of HMGB1 in NSCLC. miR-142-3p may be a tumor suppressor and a potential therapeutic agent for patients with NSCLC.
Insights
microRNA-142-3p is downregulated in non-small-cell lung carcinoma (NSCLC). Overexpressing this microRNA inhibits NSCLC cell growth and induces apoptosis, suggesting it acts as a tumor suppressor by targeting HMGB1.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are key regulators in cancer, influencing oncogenes and tumor suppressors.
- Previous studies indicated miR-142-3p downregulation in non-small-cell lung carcinoma (NSCLC).
- The precise function of miR-142-3p in NSCLC remained largely undetermined.
Purpose of the Study:
- To investigate the functional role of miR-142-3p in non-small-cell lung carcinoma.
- To identify the molecular targets and mechanisms underlying miR-142-3p's action in NSCLC.
Main Methods:
- Quantitative real-time PCR to assess miR-142-3p expression levels in NSCLC and normal tissues.
- MTT and colony formation assays to evaluate the impact of miR-142-3p on NSCLC cell proliferation.
- Luciferase reporter assays and Western blotting to confirm HMGB1 as a direct target of miR-142-3p.
Main Results:
- miR-142-3p expression was significantly downregulated in NSCLC tissues and cell lines.
- Overexpression of miR-142-3p suppressed NSCLC cell proliferation and promoted apoptosis.
- HMGB1 was identified as a direct target of miR-142-3p in NSCLC, validated by luciferase assays.
Conclusions:
- miR-142-3p functions as a tumor suppressor in NSCLC.
- The tumor-suppressive activity of miR-142-3p is mediated through the downregulation of HMGB1.
- miR-142-3p holds potential as a therapeutic target for non-small-cell lung carcinoma.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

